Volume 108, Issue 11 pp. 1686-1691
Independent Papers

An orthotopic floor-of-mouth cancer model allows quantification of tumor invasion

Christian Simon MD

Christian Simon MD

Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Department of Tumor Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Department of Otolaryngology—Head and Neck Surgery at the University of Tübingen, Germany

Search for more papers by this author
Andrew J. Nemechiek MD

Andrew J. Nemechiek MD

Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Search for more papers by this author
Douglas Boyd PhD

Douglas Boyd PhD

Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Department of Tumor Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Search for more papers by this author
Bert W. O'Malley Jr. Md

Bert W. O'Malley Jr. Md

Department of Otolaryngology—Head and Neck Surgery, John Hopkins University, Baltimore, Maryland

Search for more papers by this author
Helmuth Goepfert MD

Helmuth Goepfert MD

Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Search for more papers by this author
Catherine M. Flaitz Dds, Ms

Catherine M. Flaitz Dds, Ms

University of Texas—Dental Branch, Houston, Texas

Search for more papers by this author
M. John Hicks Md, Phd, Dds

Corresponding Author

M. John Hicks Md, Phd, Dds

Department of Pathology, Texas Children's Hospital and Baylor College of Medicine, Houston, Texas

Department of Pathology, Texas Children's Hospital, 6621 Fannin Street, MC 1–2261, Houston, TX 77030, U.S.A.Search for more papers by this author
First published: 20 October 2009
Citations: 31

Abstract

Objectives: To establish an orthotopic murine floor-of-mouth cancer model for the analysis of the role of proteases such as urokinase-type plasminogen activator (u-PA) and the matrix metalloprotease MMP-9 (MMP-9) in in vivo invasion. Study Design: Randomized, prospective animal study. Methods: Two human squamous cell carcinoma cell lines, UM-SCC-1 and 022, were assayed via zymography for their in vitro secretion levels of u-PA and MMP-9. Both cell lines (5 × 106 cells) were injected into the cervical subcutaneous tissues of female athymic nude (nu/nu) mice superficial to the mylohyoid muscle. Mice were sacrificed after 30 days, and tumor invasion characteristics were histologically compared. Additional mice were then inoculated with invasive UM-SCC-1 cells and sacrificed 10, 30, and 40 days after inoculation to identify distinct stages of invasion. Results: In vitro secretion levels of MMP-9 and activity of u-PA were higher in UM-SCC-1 cells than in 022 cells. In the in vivo studies, tumors formed from 022 cells were found to be noninvasive, whereas tumors derived from UM-SCC-1 cells progressed through distinct and readily identifiable histologic stages of invasion. These stages included invasion of adjacent muscle layers (mylohyoid, geniohyoid, and genioglossus muscles) and of associated structures (blood vessels, bone, nerve, and regional lymph nodes). A staging system was devised accordingly. Conclusion: We developed an in vivo quantitative cancer invasion model that allows determination of the effect of the expression and activity levels of the proteases MMP-9 and u-PA. Tumor invasion occurred in an orderly and stepwise fashion involving muscles and related vascular, nervous, and bony structures of the floor of the mouth and tongue. This orderly invasion allowed the development of a staging system. We anticipate that this model will have wide applicability in the study of in vivo tumor response to a variety of novel therapeutic approaches. Laryngoscope, 108:1686–1691, 1998

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.